nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Canadian Implantable Defibrillator Study (CIDS): Perspective of the Principal Investigators
|
S.J. Connolly |
|
1998 |
2 |
1 |
p. 11-12 2 p. |
artikel |
2 |
Canadian Implantable Defibrillator Study (CIDS): Perspective of the Principal Investigators
|
Connolly, S.J. |
|
1998 |
2 |
1 |
p. 11-12 |
artikel |
3 |
Clinical Cardiac Electrophysiology in Australia
|
David L. Ross |
|
1998 |
2 |
1 |
p. 73-74 2 p. |
artikel |
4 |
Clinical Cardiac Electrophysiology in Australia
|
Ross, David L. |
|
1998 |
2 |
1 |
p. 73-74 |
artikel |
5 |
Clinical Implications of ATRAMI: A Clinicians Perspective
|
Raul D. Mitrani |
|
1998 |
2 |
1 |
p. 41-43 3 p. |
artikel |
6 |
Clinical Implications of ATRAMI: A Clinician's Perspective
|
Mitrani, Raul D. |
|
1998 |
2 |
1 |
p. 41-43 |
artikel |
7 |
Clinical Implications of MADIT, AVID, CIDS, CABG Patch Trial and CASH: A North American Perspective
|
Jeremy N. Ruskin |
|
1998 |
2 |
1 |
p. 17-20 4 p. |
artikel |
8 |
Clinical Implications of MADIT, AVID, CIDS, CABG Patch Trial and CASH: A North American Perspective
|
Ruskin, Jeremy N. |
|
1998 |
2 |
1 |
p. 17-20 |
artikel |
9 |
Clinical Implications of MADIT, AVID, CIDS, the CABG Patch Trial and CASH: A European Perspective
|
M.M. Gallagher |
|
1998 |
2 |
1 |
p. 21-22 2 p. |
artikel |
10 |
Clinical Implications of MADIT, AVID, CIDS, the CABG Patch Trial and CASH: A European Perspective
|
Gallagher, M.M. |
|
1998 |
2 |
1 |
p. 21-22 |
artikel |
11 |
Clinical Implications of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial: The Investigators Perspective
|
H. Leon Green |
|
1998 |
2 |
1 |
p. 8-10 3 p. |
artikel |
12 |
Clinical Implications of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial: The Investigators' Perspective
|
Green, H. Leon |
|
1998 |
2 |
1 |
p. 8-10 |
artikel |
13 |
Clinical Implications of the CABG Patch Trial: An Investigators Perspective
|
John P. DiMarco |
|
1998 |
2 |
1 |
p. 13-15 3 p. |
artikel |
14 |
Clinical Implications of the CABG Patch Trial: An Investigator's Perspective
|
DiMarco, John P. |
|
1998 |
2 |
1 |
p. 13-15 |
artikel |
15 |
Clinical Implications of the CAMIAT, EMIAT and SWORD Trials: A European Perspective
|
Martin Borggrefe |
|
1998 |
2 |
1 |
p. 34-35 2 p. |
artikel |
16 |
Clinical Implications of the CAMIAT, EMIAT and SWORD Trials: A European Perspective
|
Borggrefe, Martin |
|
1998 |
2 |
1 |
p. 34-35 |
artikel |
17 |
Clinical Implications of the CAMIAT, EMIAT and SWORD Trials: A North American Perspective
|
Jeffrey L. Anderson |
|
1998 |
2 |
1 |
p. 30-33 4 p. |
artikel |
18 |
Clinical Implications of the CAMIAT, EMIAT and SWORD Trials: A North American Perspective
|
Anderson, Jeffrey L. |
|
1998 |
2 |
1 |
p. 30-33 |
artikel |
19 |
Clinical Implications of the CAMIAT, EMIAT and SWORD Trials: A South American Perspective
|
Hernán C. Doval |
|
1998 |
2 |
1 |
p. 36-37 2 p. |
artikel |
20 |
Clinical Implications of the CAMIAT, EMIAT and SWORD Trials: A South American Perspective
|
Doval, Hernán C. |
|
1998 |
2 |
1 |
p. 36-37 |
artikel |
21 |
Clinical Implications of the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT)
|
John A. Cairns |
|
1998 |
2 |
1 |
p. 23-25 3 p. |
artikel |
22 |
Clinical Implications of the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT)
|
Cairns, John A. |
|
1998 |
2 |
1 |
p. 23-25 |
artikel |
23 |
Clinical Implications of the European Myocardial Infarct Amiodarone Trial (EMIAT)
|
A. John Camm |
|
1998 |
2 |
1 |
p. 26-27 2 p. |
artikel |
24 |
Clinical Implications of the European Myocardial Infarct Amiodarone Trial (EMIAT)
|
Camm, A. John |
|
1998 |
2 |
1 |
p. 26-27 |
artikel |
25 |
Clinical Implications of the Multicenter Automatic Defibrillator Implantation Trial (MADIT): An Investigators Perspective
|
Arthur J. Moss |
|
1998 |
2 |
1 |
p. 6-7 2 p. |
artikel |
26 |
Clinical Implications of the Multicenter Automatic Defibrillator Implantation Trial (MADIT): An Investigator's Perspective
|
Moss, Arthur J. |
|
1998 |
2 |
1 |
p. 6-7 |
artikel |
27 |
Clinical Implications of the North American Vasovagal Pacemaker Study
|
David G. Benditt |
|
1998 |
2 |
1 |
p. 54-56 3 p. |
artikel |
28 |
Clinical Implications of the North American Vasovagal Pacemaker Study
|
Benditt, David G. |
|
1998 |
2 |
1 |
p. 54-56 |
artikel |
29 |
Clinical Implications of the Stroke Prevention in Atrial Fibrillation III Trial: A Clinicians Perspective
|
Gregory Y.H. Lip |
|
1998 |
2 |
1 |
p. 49-51 3 p. |
artikel |
30 |
Clinical Implications of the Stroke Prevention in Atrial Fibrillation III Trial: A Clinician's Perspective
|
Lip, Gregory Y.H. |
|
1998 |
2 |
1 |
p. 49-51 |
artikel |
31 |
Clinical Implications of the Survival with Oral D-Sotalol (SWORD) Trial: An Investigation of Patients with Left Ventricular Dysfunction after Myocardial Infarction
|
Craig M. Pratt |
|
1998 |
2 |
1 |
p. 28-29 2 p. |
artikel |
32 |
Clinical Implications of the Survival with Oral D-Sotalol (SWORD) Trial: An Investigation of Patients with Left Ventricular Dysfunction after Myocardial Infarction
|
Pratt, Craig M. |
|
1998 |
2 |
1 |
p. 28-29 |
artikel |
33 |
Conversion of Atrial Fibrillation: Pills, Shots, or Shocks?
|
Philip J. Podrid |
|
1998 |
2 |
1 |
p. 64-68 5 p. |
artikel |
34 |
Conversion of Atrial Fibrillation: Pills, Shots, or Shocks?
|
Podrid, Philip J. |
|
1998 |
2 |
1 |
p. 64-68 |
artikel |
35 |
Electrophysiology Practice in a Health Maintenance Organization
|
Simón Milstein |
|
1998 |
2 |
1 |
p. 89-90 2 p. |
artikel |
36 |
Electrophysiology Practice in a Health Maintenance Organization
|
Milstein, Simón |
|
1998 |
2 |
1 |
p. 89-90 |
artikel |
37 |
EP Practice Patterns, Reimbursement and Health Care Policy in Canada
|
D. George Wyse |
|
1998 |
2 |
1 |
p. 83-85 3 p. |
artikel |
38 |
EP Practice Patterns, Reimbursement and Health Care Policy in Canada
|
Wyse, D. George |
|
1998 |
2 |
1 |
p. 83-85 |
artikel |
39 |
EP Practice Patterns, Reimbursement and Health Care Policy in France
|
Pierre Maison-Blanche |
|
1998 |
2 |
1 |
p. 80-80 1 p. |
artikel |
40 |
EP Practice Patterns, Reimbursement and Health Care Policy in France
|
Maison-Blanche, Pierre |
|
1998 |
2 |
1 |
p. 80 |
artikel |
41 |
EP Practice Patterns, Reimbursement and Health Care Policy in Israel
|
Michael Glikson |
|
1998 |
2 |
1 |
p. 77-79 3 p. |
artikel |
42 |
EP Practice Patterns, Reimbursement and Health Care Policy in Israel
|
Glikson, Michael |
|
1998 |
2 |
1 |
p. 77-79 |
artikel |
43 |
EP Practice Patterns, Reimbursement and Health Care Policy in South Korea
|
You-Ho Kim |
|
1998 |
2 |
1 |
p. 71-72 2 p. |
artikel |
44 |
EP Practice Patterns, Reimbursement and Health Care Policy in South Korea
|
Kim, You-Ho |
|
1998 |
2 |
1 |
p. 71-72 |
artikel |
45 |
Evolving Indications for Permanent Pacing in Patients with Vasovagal Syncope
|
Robert S. Sheldon |
|
1998 |
2 |
1 |
p. 52-53 2 p. |
artikel |
46 |
Evolving Indications for Permanent Pacing in Patients with Vasovagal Syncope
|
Sheldon, Robert S. |
|
1998 |
2 |
1 |
p. 52-53 |
artikel |
47 |
I.V. Amiodarone: What Do We Really Know About It?
|
Raymond L. Woosley |
|
1998 |
2 |
1 |
p. 61-63 3 p. |
artikel |
48 |
I.V. Amiodarone: What Do We Really Know About It?
|
Woosley, Raymond L. |
|
1998 |
2 |
1 |
p. 61-63 |
artikel |
49 |
Overview of the National Health Care System
|
Ali Oto |
|
1998 |
2 |
1 |
p. 75-76 2 p. |
artikel |
50 |
Overview of the National Health Care System
|
Oto, Ali |
|
1998 |
2 |
1 |
p. 75-76 |
artikel |
51 |
Practice of Electrophysiology in Taiwan
|
Delon Wu |
|
1998 |
2 |
1 |
p. 69-70 2 p. |
artikel |
52 |
Practice of Electrophysiology in Taiwan
|
Wu, Delon |
|
1998 |
2 |
1 |
p. 69-70 |
artikel |
53 |
Private EP Practice in a Strong HMO Environment
|
David S. Cannom |
|
1998 |
2 |
1 |
p. 86-88 3 p. |
artikel |
54 |
Private EP Practice in a Strong HMO Environment
|
Cannom, David S. |
|
1998 |
2 |
1 |
p. 86-88 |
artikel |
55 |
Quality Assurance in Pacing and Electrophysiology
|
Mark H. Schoenfeld |
|
1998 |
2 |
1 |
p. 94-96 3 p. |
artikel |
56 |
Quality Assurance in Pacing and Electrophysiology
|
Schoenfeld, Mark H. |
|
1998 |
2 |
1 |
p. 94-96 |
artikel |
57 |
Sequential Designs in Clinical Trials
|
David L. DeMets |
|
1998 |
2 |
1 |
p. 57-60 4 p. |
artikel |
58 |
Sequential Designs in Clinical Trials
|
DeMets, David L. |
|
1998 |
2 |
1 |
p. 57-60 |
artikel |
59 |
Spaf III Trial: Of Risk Stratification and Minimal Effective Warfarin Intensity
|
Joseph L. Blackshear |
|
1998 |
2 |
1 |
p. 44-48 5 p. |
artikel |
60 |
Spaf III Trial: Of Risk Stratification and Minimal Effective Warfarin Intensity
|
Blackshear, Joseph L. |
|
1998 |
2 |
1 |
p. 44-48 |
artikel |
61 |
The ATRAMI Prospective Study: Implications for Risk Stratification after Myocardial Infarction
|
Peter J. Schwartz |
|
1998 |
2 |
1 |
p. 38-40 3 p. |
artikel |
62 |
The ATRAMI Prospective Study: Implications for Risk Stratification after Myocardial Infarction
|
Schwartz, Peter J. |
|
1998 |
2 |
1 |
p. 38-40 |
artikel |
63 |
The Cardiac Arrest Study Hamburg (CASH)
|
Riccardo Cappato |
|
1998 |
2 |
1 |
p. 16-16 1 p. |
artikel |
64 |
The Cardiac Arrest Study Hamburg (CASH)
|
Cappato, Riccardo |
|
1998 |
2 |
1 |
p. 16 |
artikel |
65 |
The Practice of Electrophysiology in Italy
|
Michele Brignole |
|
1998 |
2 |
1 |
p. 81-82 2 p. |
artikel |
66 |
The Practice of Electrophysiology in Italy
|
Brignole, Michele |
|
1998 |
2 |
1 |
p. 81-82 |
artikel |
67 |
What to Expect from the 105th Congress: A View from Inside the Beltway
|
Dan Nickelson |
|
1998 |
2 |
1 |
p. 97-98 2 p. |
artikel |
68 |
What to Expect from the 105th Congress: A View from Inside the Beltway
|
Nickelson, Dan |
|
1998 |
2 |
1 |
p. 97-98 |
artikel |
69 |
Workforce Planning in a Changing Environment: How Much is Enough?
|
Alan Morgan |
|
1998 |
2 |
1 |
p. 99-100 2 p. |
artikel |
70 |
Workforce Planning in a Changing Environment: How Much is Enough?
|
Morgan, Alan |
|
1998 |
2 |
1 |
p. 99-100 |
artikel |
71 |
Working Toward an Efficient Electrophysiology Practice
|
Antonio Pacifico |
|
1998 |
2 |
1 |
p. 91-93 3 p. |
artikel |
72 |
Working Toward an Efficient Electrophysiology Practice
|
Pacifico, Antonio |
|
1998 |
2 |
1 |
p. 91-93 |
artikel |